Symbols

GMED

Globus Medical·NYSE

--(--)

Signals Analysis

Bullish signal 6

Bearish signal 1

Consensus Rating "Buy"

MACD Golden Cross

Ample Liquidity

High Gross Profit Margin

Significant Net Income Growth

High Cash/net Profit Ratio

EPS Below Expectations

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About GMED

Globus Medical, Inc.

A leading musculoskeletal solutions company

Industry

Healthcare Equipment and Supplies

Established Date

Listing Date

08/03/2012

Exchange

New York Stock Exchange

Full-time Employees

6,000

Fiscal Year Ends

12-31

Website

www.globusmedical.com

Security Type

Common stock

Office address

2560 General Armistead Avenue , Audubon , PA 19403-5214

Business

Introduction

Globus Medical, Inc., was incorporated in Delaware in March 2003. As a medical device manufacturing company, Globus is fully focused on the design, development and commercialization of its products, which can promote the recovery of patients with spinal diseases. Globus products are divided into two categories, namely innovation and integration and disruptive technology.

Company Financials

EPS

GMED has released its 2025 Q4 earnings. EPS was reported at 1.28, versus the expected 1.11, beating expectations. The chart below visualizes how GMED has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

GMED has released its 2025 Q4 earnings report, with revenue of 826.42M, reflecting a YoY change of 25.73%, and net profit of 140.59M, showing a YoY change of 430.44%. The Sankey diagram below clearly presents GMED's revenue sources and cost distribution.